All over the world, scientific discoveries and their medical potential are redefining the way society, politics and the medical community think about Cannabis as a plant.
Our team looks back on a strong track record in building and scaling companies in various industries, creating hundreds of jobs and millions in shareholder value in the process. Being joined by renowned industry leaders and medical experts, Sanity Group continuously positions itself on the brink of innovation and is equipped to shape the Cannabis industry in Europe.
We provide a unique community of industry experts, excellent talent, operational backing, and capital to our fast-growing portfolio of ventures.
We believe that everybody deserves to live a healthy life. After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives.
Therefore, it is our purpose to develop innovative cannabinoid-based pharmaceuticals & wellbeing products and make them widely accessible.
To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application. Equipped with this knowledge, we educate healthcare professionals, patients and consumers and support them to live a healthier life.